Consumer Law

A federal judge declined to certify a class, but denied Pfizer’s request for summary judgment on claims it charged more for Maximum Strength Robitussin cough syrup than for Regular Strength Robitussin when the former had a lower concentration of active ingredients than the latter.

CHICAGO — A federal judge declined to certify a class, but denied Pfizer summary judgment on claims it charged more for Maximum Strength Robitussin cough syrup than for Regular Strength Robitussin, when the former had a lower concentration of active ingredients than the latter.

Categories / Business, Consumers

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Consumer Law

Subscribe to Closing Arguments

Additional Reads